OPKO Health to Announce 2016 Fourth Quarter Financial Results on March 1, 2017

Feb 27, 2017

OPKO Health to Participate at Upcoming Healthcare Investment Conferences

Feb 21, 2017

OPKO Spain to Start Trial of Once-A-Year Intra-Articular Injectable for Osteoarthritis

Feb 8, 2017

OPKO Health Promotes Thomas Nusbickel to Renal Division Chief Commercial Officer

Feb 7, 2017

OPKO’S GeneDx Announces Research Collaboration with the Wellcome Trust Sanger Institute

Feb 1, 2017

OPKO Investee Zebra Biologics Announces Collaboration with AbbVie to Discover New Antibody Therapeutics

Jan 10, 2017

OPKO Announces Initiation of Claros® 1 Clinical Trial for Total PSA

Jan 9, 2017

OPKO Health to Present at the J.P. Morgan 35th Annual Healthcare Conference

Jan 4, 2017

OPKO Health Provides Update on hGH-CTP Clinical Programs

Dec 30, 2016

OPKO Health to be Added to the NASDAQ Biotechnology Index

Dec 19, 2016